Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Shrikant Kulkarni"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 08, Pp 17-21 (2023)
Introduction: Arthroscopic Anterior Cruciate Ligament (ACL) reconstruction using hamstring tendon autografts is commonly used in day-to-day practice. Recently, the quadriceps tendon has been considered as a graft choice for primary ACL reconstruct
Externí odkaz:
https://doaj.org/article/2685e14b046949c290acfeaadfc272c7
Autor:
Bhaskar Musmade, Prashant Sanatan, Surbhi Lokhande, Shrikant Kulkarni, Shrinivas Bhope, Sriram Padmanabhan, Amol Pachpinde, Kishan Lohar
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background A simple, robust, precise, and an accurate HPLC method was established for simultaneous estimation of xylometazoline hydrochloride and ipratropium bromide from a nasal spray dosage form. The effective separation was obtained by in
Externí odkaz:
https://doaj.org/article/e6a7495085864f34905bb520baaaadb1
Autor:
N. V. Jadhav, Vivek M. Patil, Shrikant Kulkarni, Pradeep Swamy, Siddalingswamy Hiremath, K. Ravikanth, Adarsh Choudhary, Shivi Maini
Publikováno v:
Journal of Advanced Veterinary and Animal Research, Vol 3, Iss 3, Pp 268-273 (2016)
Objective: Efficacy of AV/CSP/29 premix (Ca, P supplement with Vit. A and D3 along with synergistic herbs) (M/S Ayurvet Ltd.) was evaluated in commercial broiler chicks. Materials and methods: A total of 144 day-old chicks were randomly divided into
Externí odkaz:
https://doaj.org/article/ed142c99fb7247aeb403893c5d65fac1
Publikováno v:
In Energy Procedia June 2017 117:1062-1069
Autor:
DR. VARINDER KAUR, Shrikant Kulkarni
Publikováno v:
Pharmaceutical Patent Analyst. 11:165-174
This research plans to explore the risks of the investment claims involved in the ongoing technology transfers to COVID-19 vaccine manufacturers based on the recently approved ‘Agreement on Trade-Related Aspects of Intellectual Property Rights' (TR
Autor:
Sadanand YEWALE, Zeba FARASH, Shrikant KULKARNI, Shital PALGHADMAL, Neelam ATHAWALE, Laxman SAWANT, Shrinivas BHOPE, Sriram PADMANABHAN
Publikováno v:
Fabad Journal of Pharmaceutical Sciences. 1:1-12
Autor:
Shri. Shrikant Kulkarni
Bamanachi por bhavasobat shalelageli. Akshar vachun shikayala lagali. Maitrinisaing nachgani shikali. Spardha madhun bakshish patakavali.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799d0bb3c9c82a732d31a853bdedaa7c
Autor:
Nita Shrikant, Kulkarni
Publikováno v:
American family physician. 106(6)
Autor:
Monita Shrikant Kulkarni
Publikováno v:
IP International Journal of Medical Microbiology and Tropical Diseases. 8:137-139
The study was carried out in a tertiary care hospital in Mumbai. A total of 65 fungal isolates from corneal scrapings taken from corneal ulcers were considered. Microscopy was doen using 20% KOH. The culture was done using Sabourauds Dextrose Agar sl
Autor:
Kuldeep Hemraj Ramteke, Varsha Balaji Jadhav, Nilesh Shrikant Kulkarni, Amol Rameshrao Kharat, Sonali Bhima Diwate
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 5, Iss 3, Pp 361-371 (2015)
Purpose: A Multiparticulate system of Mebendazole was developed for colon targeted drug delivery by using natural polysaccharides like Chitosan and Sodium-alginate beads. Methods: Chitosan microspheres were formulated by using Emulsion crosslinking
Externí odkaz:
https://doaj.org/article/af65397e7094414a900fed118b9729d5